SYNGENE INTERNATIONAL Fact Sheet, SYNGENE INTERNATIONAL Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNGENE INTERNATIONAL Fact Sheet    (SYNGE)


WATCH NOW: Top 3 Stocks for 2022 MEGA Summit... For free


Here is the latest financial fact sheet of SYNGENE INTERNATIONAL. For more details, see the SYNGENE INTERNATIONAL quarterly results and SYNGENE INTERNATIONAL share price and chart. For a sector overview, read our pharmaceuticals sector report.

SYNGENE INTERNATIONAL Price History

Price Rs 611.3
Mkt Cap Rs m 245,007
Vol '000 12.1
P/E X 60.2
P/CF X 36.1
EPS (TTM) Rs 10.1
1 Day % -2.1
No. of shares m 400.80
1 Week % -2.7
1 Month % 4.7
1 Year % 4.3
52 week H/L Rs 700.0/490.4
As on Jan 18, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SYNGENE INTERNATIONAL Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SYNGENE INTERNATIONAL EQUITY SHARE DATA
High Rs663670700702645 
Low Rs349430509202230 
Sales per share (Unadj.) Rs60.071.291.350.354.6 
Earnings per share (Unadj.) Rs14.415.316.610.310.1 
Diluted earnings per shareRs7.27.68.310.310.1 
Cash flow per share (Unadj.) Rs20.121.824.815.817.0 
Dividends per share (Unadj.) Rs1.001.000.5000 
Adj. dividends per shareRs0.500.500.250.000.00 
Avg Dividend yield %0.20.20.100 
Book value per share (Unadj.) Rs69.484.697.053.468.6 
Adj. book value per shareRs34.642.248.453.368.5 
Shares outstanding (eoy) m200.00200.00200.00400.00400.00 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x8.47.76.69.08.0 
Avg P/E ratio x35.236.036.543.943.2 
P/CF ratio (eoy) x25.225.224.428.625.7 
Price / Book Value ratio x7.36.56.28.56.4 
Dividend payout %7.06.53.000 
Avg Mkt Cap Rs m101,230110,000120,910180,820174,930 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,0863,7964,7275,8046,602 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SYNGENE INTERNATIONAL INCOME DATA
Net Sales Rs m12,00914,23118,25620,11921,843 
Other income Rs m9361,361762961833 
Total revenues Rs m12,94515,59219,01821,08022,676 
Gross profit Rs m3,8473,9055,3576,7476,881 
Depreciation Rs m1,1431,3141,6422,1932,745 
Interest Rs m175227323346277 
Profit before tax Rs m3,4653,7254,1545,1694,692 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m5926718381,048643 
Profit after tax Rs m2,8733,0543,3164,1214,049 
Gross profit margin %32.027.429.333.531.5 
Effective tax rate %17.118.020.220.313.7 
Net profit margin %23.921.518.220.518.5 
SYNGENE INTERNATIONAL BALANCE SHEET DATA
Current assets Rs m15,24117,20217,64116,12618,067 
Current liabilities Rs m6,0037,83611,28615,39211,330 
Net working cap to sales %76.965.834.83.630.8 
Current ratio x2.52.21.61.01.6 
Inventory Days Days22694191172169 
Debtors Days Days6068687257 
Net fixed assets Rs m11,87013,96418,47924,27629,874 
Share capital Rs m2,0002,0002,0004,0004,000 
"Free" reserves Rs m11,87914,92217,40417,36923,444 
Net worth Rs m13,87916,92219,40421,36927,444 
Long term debt Rs m6,8985,8553,46605,124 
Total assets Rs m27,11131,16636,12040,40247,941 
Interest coverage x20.817.413.915.917.9 
Debt to equity ratio x0.50.30.200.2 
Sales to assets ratio x0.40.50.50.50.5 
Return on assets %11.210.510.111.19.0 
Return on equity %20.718.017.119.314.8 
Return on capital %17.517.419.625.815.3 
Exports to sales %00000 
Imports to sales %32.028.633.926.325.3 
Exports (fob) Rs m00000 
Imports (cif) Rs m3,8484,0716,1885,2875,521 
Fx inflow Rs m11,40712,82816,41318,47620,215 
Fx outflow Rs m3,8484,0716,1885,2875,521 
Net fx Rs m7,5598,75710,22513,18914,694 
SYNGENE INTERNATIONAL CASH FLOW
From Operations Rs m 3,981 4,462 6,304 6,771 7,012 
From Investments Rs m -4,691 -3,493 -6,465 -4,284 -6,281 
From Financial Activity Rs m -812 -787 -724 -2,255 580 
Net Cashflow Rs m -1,528 182 -875 278 1,303 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 70.4%
Institution 18.3%
Non-Institution 11.3%
Total 100.0%
Free Float 29.6%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off Biocon Sez Biocon Park No 2 & 3 Bommasandra, Industrail Area Iv Pahse, Jigani Link Rd, Bengaluru - 560099
E-mail investor@syngeneintl.com Web www.syngeneintl.com
Tel 080 6891 8000\5000 Fax 080 6891 8808
Sector MISCELLANEOUS Group Private sector
Tr Agent K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
YEAR OF INC: 1993 BSE CODE: 539268 FV (Rs): 10 DIV YIELD (%): -

Read: SYNGENE INTERNATIONAL 2020-21 Annual Report Analysis

More Miscellaneous Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare SYNGENE INTERNATIONAL With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Sensex Tanks 554 Points, Nifty Ends Near 18,100; Maruti, Tech Mahindra & Tata Consumer Plunge 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

SYNGENE INTERNATIONAL Announces Quarterly Results (2QFY22); Net Profit Down 20.7% (Quarterly Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

For the quarter ended September 2021, SYNGENE INTERNATIONAL has posted a net profit of Rs 667 m (down 20.7% YoY). Sales on the other hand came in at Rs 6 bn (up 17.4% YoY). Read on for a complete analysis of SYNGENE INTERNATIONAL's quarterly results.

SYNGENE INTERNATIONAL 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SYNGENE INTERNATIONAL for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SYNGENE INTERNATIONAL. Also includes updates on the valuation of SYNGENE INTERNATIONAL.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks Views On News (Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You (Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SYNGENE INTERNATIONAL

  • Track your investment in SYNGENE INTERNATIONAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SYNGENE INTERNATIONAL

SYNGENE INTERNATIONAL - VANTA BIOSCIENCE COMPARISON

COMPARE SYNGENE INTERNATIONAL WITH

MARKET STATS